» Articles » PMID: 35927462

Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation

Citing Articles

Comparing Kramer's rule with transcutaneous bilirubin vs. Kramer's rule only in reducing total serum bilirubin sampling among neonates with jaundice.

Lim X, Ambigapathy S, Leong E, Marmuji L, Phan A, Hamdan F BMC Pediatr. 2025; 25(1):169.

PMID: 40045227 PMC: 11884148. DOI: 10.1186/s12887-025-05423-z.


Assessing accuracy of BiliPredics algorithm in predicting individual bilirubin progression in neonates-results from a prospective multi-center study.

Steffens B, Koch G, Engel C, Franz A, Pfister M, Wellmann S Front Digit Health. 2025; 7:1497165.

PMID: 40041127 PMC: 11878101. DOI: 10.3389/fdgth.2025.1497165.


Characterization of severity of hemolytic disease of the fetus and newborn due to Rhesus antigen alloimmunization.

Krumme A, Suruki R, Blacketer C, Hardin J, Swerdel J, Tjoa M AJOG Glob Rep. 2025; 5(1):100439.

PMID: 40034827 PMC: 11872512. DOI: 10.1016/j.xagr.2024.100439.


Hyperbilirubinemia Requiring Exchange Transfusion as a Risk Factor for Later-Onset Hearing Loss.

Wiley S, Kaul V, Adunka O, Iwamoto L, Nutt R, Coverstone K J Early Hear Detect Interv. 2025; 9(2):1-18.

PMID: 40034216 PMC: 11875398.


End-tidal carbon monoxide for routine monitoring of significant hemolysis in the management of newborn hyperbilirubinemia.

Wells S, Balasubramanian R, Nguyen K, Schutzman D J Perinatol. 2025; .

PMID: 40011553 DOI: 10.1038/s41372-025-02242-z.